U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula Ti
Molecular Weight 47.867
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of TITANIUM

SMILES

[Ti]

InChI

InChIKey=RTAQQCXQSZGOHL-UHFFFAOYSA-N
InChI=1S/Ti

HIDE SMILES / InChI

Description
Curator's Comment: description was created based on several sources, including https://www.accessdata.fda.gov/drugsatfda_docs/nda/2008/022009s000_ClinPharmR.pdf | https://www.ncbi.nlm.nih.gov/pubmed/18503414

Titanium dioxide, also known as titanium(IV) oxide or titania, is the naturally occurring oxide of titanium, chemical formula TiO 2. When used as a pigment, it is called titanium white, Pigment White 6 (PW6), or CI 77891. Generally it is sourced from ilmenite, rutile and anatase. It has a wide range of applications, from paint to sunscreen to food coloring. When used as a food coloring, it has E number E171. World production in 2014 exceeded 9 million metric tons. Titanium dioxide has excellent ultraviolet (UV) resistant qualities and acts as a UV absorbent. In the pharmaceutical industry, titanium dioxide is used in most sunscreens to block UVA and UVB rays, similar to zinc oxide. It is also commonly used as pigment for pharmaceutical products such as gelatin capsules, tablet coatings and syrups. In the cosmetics industry, it is used in toothpaste, lipsticks, creams, ointments and powders. It can be used as an opacifier to make pigments opaque. The FDA has approved the safety of titanium dioxide for use as a colorant in food, drugs and cosmetics, including sunscreens. However, controversy exists as to the safety of titanium dioxide nanoparticles used in the cosmetics industry, for example in sunscreens. Titanium and zinc oxides may be made into the nanoparticle size (0.2-100 nanometers) to reduce the white appearance when applied topically, but retain the UV blocking properties. Recent studies suggest titanium dioxide nanoparticles may be toxic, although further research is needed.

CNS Activity

Curator's Comment: https://www.accessdata.fda.gov/drugsatfda_docs/nda/2008/022009s000_ClinPharmR.pdf

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
Target ID: ultraviolet induced damage
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Preventing
ANTHELIOS 40

Approved Use

Unknown

Launch Date

1.20692159E12
Primary
Unknown

Approved Use

Unknown
PubMed

PubMed

TitleDatePubMed
Increased expression of manganese-containing superoxide dismutase in rat lungs after inhalation of inflammatory and fibrogenic minerals.
1994 Mar
Cytokine and prostaglandin E2 release from leukocytes in response to metal ions derived from different prosthetic materials: an in vitro study.
1999 Dec
The effects of particulate wear debris, cytokines, and growth factors on the functions of MG-63 osteoblasts.
2001 Feb
Chemokine gene activation in human bone marrow-derived osteoblasts following exposure to particulate wear debris.
2006 Apr
Pulmonary exposure to particles during pregnancy causes increased neonatal asthma susceptibility.
2008 Jan
Differential binding of inorganic particles to MARCO.
2009 Jan
Induction of chronic inflammation in mice treated with titanium dioxide nanoparticles by intratracheal instillation.
2009 Jun 16
Airway exposure to silica-coated TiO2 nanoparticles induces pulmonary neutrophilia in mice.
2010 Feb
Engineered nanomaterials cause cytotoxicity and activation on mouse antigen presenting cells.
2010 Jan 12
Pulmonary response to surface-coated nanotitanium dioxide particles includes induction of acute phase response genes, inflammatory cascades, and changes in microRNAs: a toxicogenomic study.
2011 Jul
Titanium oxide shell coatings decrease the cytotoxicity of ZnO nanoparticles.
2011 Mar 21
Safety evaluation of sunscreen formulations containing titanium dioxide and zinc oxide nanoparticles in UVB sunburned skin: an in vitro and in vivo study.
2011 Sep
Gene expression of zebrafish embryos exposed to titanium dioxide nanoparticles and hydroxylated fullerenes.
2011 Sep
DNA damage and alterations in expression of DNA damage responsive genes induced by TiO2 nanoparticles in human hepatoma HepG2 cells.
2011 Sep
Molecular control of TiO₂-NPs toxicity formation at predicted environmental relevant concentrations by Mn-SODs proteins.
2012
TiO₂ nanoparticles induce dysfunction and activation of human endothelial cells.
2012 Apr 16
Titanium dioxide nanoparticles inhibit proliferation and induce morphological changes and apoptosis in glial cells.
2012 Dec 16
Distinct immunomodulatory effects of a panel of nanomaterials in human dermal fibroblasts.
2012 May 5
Four types of inorganic nanoparticles stimulate the inflammatory reaction in brain microglia and damage neurons in vitro.
2012 Oct 17
Molecular mechanisms of nanosized titanium dioxide-induced pulmonary injury in mice.
2013
Differential mouse pulmonary dose and time course responses to titanium dioxide nanospheres and nanobelts.
2013 Jan
TiO2, CeO2 and ZnO nanoparticles and modulation of the degranulation process in human neutrophils.
2013 Jul 31
Zinc oxide nanoparticles induce migration and adhesion of monocytes to endothelial cells and accelerate foam cell formation.
2014 Jul 1
Effects of titanium dioxide nanoparticles on lead bioconcentration and toxicity on thyroid endocrine system and neuronal development in zebrafish larvae.
2015 Apr
Release of titanium ions from an implant surface and their effect on cytokine production related to alveolar bone resorption.
2015 Jan 2
Titanium dioxide nanoparticles modulate the toxicological response to cadmium in the gills of Mytilus galloprovincialis.
2015 Oct 30
Patents

Sample Use Guides

Apply evenly 15 minutes before sun exposure. Reapply as needed or after towel drying, swimming, or perspiring. Children under 6 months of age, ask a doctor.
Route of Administration: Topical
For the in vitro studies, the stratum corneum side of the skin was in contact with either the aqueous or oily commercial dispersion of microfine TiO2 (150 μl/cm^2). The dermis side was placed onto a tissue of cellulose soaked with isotonic phosphate buffered saline (PBS) of pH 7.4. Twenty-four hours after application of the dispersion, the PBS was removed from the skin with a dry paper towel. For the in vivo studies, 2 μl cm−2 of the commercial dispersions and the different formulations were applied onto the ventral side of the forearm of a healthy female volunteer. After 45 min, any dispersion or formulation that had not penetrated the skin was also removed with a paper towel. All penetration tests were performed in triplicate.
Name Type Language
TITANIUM
HSDB   MART.   MI   WHO-DD  
Systematic Name English
TITANIUM [MI]
Common Name English
TITANIUM ELEMENT
Common Name English
TITANIUM [MART.]
Common Name English
TITANIUM METALLICUM
HPUS  
Common Name English
TITANIUM METALLICUM [HPUS]
Common Name English
Titanium [WHO-DD]
Common Name English
TITANIUM [HSDB]
Common Name English
Classification Tree Code System Code
DSLD 2074 (Number of products:31)
Created by admin on Fri Dec 15 16:08:44 UTC 2023 , Edited by admin on Fri Dec 15 16:08:44 UTC 2023
NCI_THESAURUS C637
Created by admin on Fri Dec 15 16:08:44 UTC 2023 , Edited by admin on Fri Dec 15 16:08:44 UTC 2023
Code System Code Type Description
EVMPD
SUB35397
Created by admin on Fri Dec 15 16:08:44 UTC 2023 , Edited by admin on Fri Dec 15 16:08:44 UTC 2023
PRIMARY
FDA UNII
D1JT611TNE
Created by admin on Fri Dec 15 16:08:44 UTC 2023 , Edited by admin on Fri Dec 15 16:08:44 UTC 2023
PRIMARY
MERCK INDEX
m10896
Created by admin on Fri Dec 15 16:08:44 UTC 2023 , Edited by admin on Fri Dec 15 16:08:44 UTC 2023
PRIMARY Merck Index
DAILYMED
D1JT611TNE
Created by admin on Fri Dec 15 16:08:44 UTC 2023 , Edited by admin on Fri Dec 15 16:08:44 UTC 2023
PRIMARY
EPA CompTox
DTXSID3047764
Created by admin on Fri Dec 15 16:08:44 UTC 2023 , Edited by admin on Fri Dec 15 16:08:44 UTC 2023
PRIMARY
RXCUI
1305547
Created by admin on Fri Dec 15 16:08:44 UTC 2023 , Edited by admin on Fri Dec 15 16:08:44 UTC 2023
PRIMARY RxNorm
CAS
7440-32-6
Created by admin on Fri Dec 15 16:08:44 UTC 2023 , Edited by admin on Fri Dec 15 16:08:44 UTC 2023
PRIMARY
HSDB
868
Created by admin on Fri Dec 15 16:08:44 UTC 2023 , Edited by admin on Fri Dec 15 16:08:44 UTC 2023
PRIMARY
CHEBI
33341
Created by admin on Fri Dec 15 16:08:44 UTC 2023 , Edited by admin on Fri Dec 15 16:08:44 UTC 2023
PRIMARY
ECHA (EC/EINECS)
231-142-3
Created by admin on Fri Dec 15 16:08:44 UTC 2023 , Edited by admin on Fri Dec 15 16:08:44 UTC 2023
PRIMARY
NCI_THESAURUS
C95189
Created by admin on Fri Dec 15 16:08:44 UTC 2023 , Edited by admin on Fri Dec 15 16:08:44 UTC 2023
PRIMARY
DRUG BANK
DB14160
Created by admin on Fri Dec 15 16:08:44 UTC 2023 , Edited by admin on Fri Dec 15 16:08:44 UTC 2023
PRIMARY
PUBCHEM
23963
Created by admin on Fri Dec 15 16:08:44 UTC 2023 , Edited by admin on Fri Dec 15 16:08:44 UTC 2023
PRIMARY
MESH
D014025
Created by admin on Fri Dec 15 16:08:44 UTC 2023 , Edited by admin on Fri Dec 15 16:08:44 UTC 2023
PRIMARY